 In-PharmaTechnologist.com |
Prosonix teams with ICL to assess MCPs for COPD and asthma
In-PharmaTechnologist.com Prosonix aims to develop new treatments for respiratory diseases though an R&D accord formed with Imperial College London (ICL). |
View full post on asthma – Google News